ausblenden:
Schlagwörter:
AGGREGATION INHIBITOR THERAPY; CENTRAL-NERVOUS-SYSTEM; NEUROTROPHIC
FACTOR; TAU-AGGREGATION; A-BETA; SUBVENTRICULAR ZONE; DENTATE GYRUS;
BRAIN; NEUROGENESIS; MICENeurosciences & Neurology; Adult stem cells; Alzheimer's disease; methylene blue; neural plasticity;
Zusammenfassung:
An interest in neurogenesis in the adult human brain as a relevant and targetable process has emerged as a potential treatment option for Alzheimer's disease and other neurodegenerative conditions. The aim of this study was to investigate the effects of tetramethylthionine chloride (methylene blue, MB) on properties of adult murine neural stem cells. Based on recent clinical studies, MB has increasingly been discussed as a potential treatment for Alzheimer's disease. While no differences in the proliferative capacity were identified, a general potential of MB in modulating the migratory capacity of adult neural stem cells was indicated in a cell mobility assay. To our knowledge, this is the first time that MB could be associated with neural mobility. The results of this study add insight to the spectrum of features of MB within the central nervous system and may be helpful for understanding the molecular mechanisms underlying a potential therapeutic effect of MB.
